The first step in utilizing immune-modulating therapies: immune status determination

Recently, a single center study conducted by Oiva and coworkers and published in Critical Care demonstrated that phospho-specific whole blood flow cytometry could be used to assess activated signaling pathways in leukocytes isolated from pancreatitis patients. The authors demonstrated that this methodology had the potential to determine the current status of a patient's immune state. Although the experimental cohort was clinically homogeneous, the observed data were heterogeneous. Altogether, these results suggest that prior to administering immune-modulatory therapies in inflammatory diseases, it will be beneficial to first determine immune status. Rapid results from whole blood phospho-specific flow cytometry may allow for determination of immune status, improve early diagnosis, and provide a rational basis for immunomodulatory therapies

Some Factors Influencing Purchase Decision-Making and Methods of Financing Selected Major Household Equipment by Arizona Families

This item is part of the Agricultural Experiment Station archive. It was digitized from a physical copy provided by the University Libraries at the University of Arizona. For more information, please email CALS Publications at [email protected]

Prevention of Immune Cell Apoptosis as Potential Therapeutic Strategy for Severe Infections

Lymphocyte apoptosis prevention may improve survival

Investigation of the Flavouring and Taste Components of Irish Seaweeds

This report outlines the methodology and results of the acquisition of new knowledge and the development of new skills to enable CyberColloids to produce commercially attractive, seaweed derived flavour ingredients for the food industry.Marine Research Sub-Programme 2007-'13, Industry Led award, Project Reference ILA/07/04Funder: Marine Institut